December’s issue of Endocrine-Related Cancer features an interesting series of thematic reviews centred on hormone-mediated cancers, focusing on prostate cancer and breast cancer.

The six reviews present a tour de force of the key concepts, novel aspects and current therapeutic challenges and emerging treatment options for these two prominent cancers. Emerging therapeutic strategies to overcome resistance to hormonal therapies and advances in patient-derived xenografts to better model solid tumours are presented.

This interesting and stimulating collection of articles provides much food for thought: a ‘must read’.

Read the full section in Endocrine-Related Cancer 23 E9–E12, T179–T270